Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E H Herman

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Cancer Treatment Reports|November 1, 1979
Acute cardiovascular alterations induced by low doses of adriamycin, rubidazone, and daunorubicin in the anesthetized beagle dogE H Herman, R S Young
Cancer Chemotherapy and Pharmacology|January 1, 1986
Pretreatment with ICRF-187 provides long-lasting protection against chronic daunorubicin cardiotoxicity in rabbitsE H Herman, V J Ferrans
Seminars in Oncology|October 13, 1998
Preclinical animal models of cardiac protection from anthracycline-induced cardiotoxicityE H Herman, V J Ferrans
Pharmacology|January 1, 1970
The acute pharmacological actions of daunomycin in the dog and monkeyE H Herman, J A Vick
Pharmacology|January 1, 1971
An isolated dog or monkey heart preparation for studying cardioactive compoundsJ A Vick, E H Herman
Toxicology and Applied Pharmacology|September 1, 1973
The cardiovascular actions of thalicarpineE H Herman, D P Chadwick
Pharmacology|January 1, 1974
Cardiovascular effects of d-tetrandrineE H Herman, D P Chadwick
Cancer Chemotherapy and Pharmacology|January 1, 1993
Timing of treatment with ICRF-187 and its effect on chronic doxorubicin cardiotoxicityE H Herman, V J Ferrans
Toxicology and Applied Pharmacology|January 1, 1970
Cardiovascular effects of guanazoleJ A Vick, E H Herman
Life Sciences. Pt. 2: Biochemistry, General and Molecular Biology|December 22, 1970
Initial studies with a brain catalaseE H Herman, T N Burbridge
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Cancer Treatment Reports|November 1, 1979
Acute cardiovascular alterations induced by low doses of adriamycin, rubidazone, and daunorubicin in the anesthetized beagle dogE H Herman, R S Young
Cancer Chemotherapy and Pharmacology|January 1, 1986
Pretreatment with ICRF-187 provides long-lasting protection against chronic daunorubicin cardiotoxicity in rabbitsE H Herman, V J Ferrans
Seminars in Oncology|October 13, 1998
Preclinical animal models of cardiac protection from anthracycline-induced cardiotoxicityE H Herman, V J Ferrans
Pharmacology|January 1, 1970
The acute pharmacological actions of daunomycin in the dog and monkeyE H Herman, J A Vick
Pharmacology|January 1, 1971
An isolated dog or monkey heart preparation for studying cardioactive compoundsJ A Vick, E H Herman
Toxicology and Applied Pharmacology|September 1, 1973
The cardiovascular actions of thalicarpineE H Herman, D P Chadwick
Pharmacology|January 1, 1974
Cardiovascular effects of d-tetrandrineE H Herman, D P Chadwick
Cancer Chemotherapy and Pharmacology|January 1, 1993
Timing of treatment with ICRF-187 and its effect on chronic doxorubicin cardiotoxicityE H Herman, V J Ferrans
Toxicology and Applied Pharmacology|January 1, 1970
Cardiovascular effects of guanazoleJ A Vick, E H Herman
Life Sciences. Pt. 2: Biochemistry, General and Molecular Biology|December 22, 1970
Initial studies with a brain catalaseE H Herman, T N Burbridge
Pageof 9